Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
11(41%)
Results Posted
13%(1 trials)
Terminated
2(7%)

Phase Distribution

Ph not_applicable
8
30%
Ph phase_1
2
7%
Ph phase_2
10
37%
Ph phase_3
2
7%

Phase Distribution

2

Early Stage

10

Mid Stage

2

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
2(9.1%)
Phase 2Efficacy & side effects
10(45.5%)
Phase 3Large-scale testing
2(9.1%)
N/ANon-phased studies
8(36.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

8 of 12 finished

Non-Completion Rate

33.3%

4 ended early

Currently Active

11

trials recruiting

Total Trials

27

all time

Status Distribution
Active(14)
Completed(8)
Terminated(4)
Other(1)

Detailed Status

Recruiting8
Completed8
Not yet recruiting3
Active, not recruiting3
Withdrawn2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
27
Active
11
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (9.1%)
Phase 210 (45.5%)
Phase 32 (9.1%)
N/A8 (36.4%)

Trials by Status

unknown14%
not_yet_recruiting311%
withdrawn27%
recruiting830%
active_not_recruiting311%
completed830%
terminated27%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT05863351Phase 3

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

Active Not Recruiting
NCT07274774Phase 2

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Recruiting
NCT06649058Phase 2

EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active

Recruiting
NCT06254248Phase 2

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

Recruiting
NCT02735252Not Applicable

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

Active Not Recruiting
NCT05223803Phase 2

TERPS Trial for de Novo Oligometastic Prostate Cancer

Recruiting
NCT06927635Phase 2

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Recruiting
NCT07156617

A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data

Not Yet Recruiting
NCT06427252Phase 2

The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM

Active Not Recruiting
NCT06422247

Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

Completed
NCT03523351Phase 1

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

Completed
NCT03904927Phase 2

Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Completed
NCT06613269Phase 2

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

Recruiting
NCT06160167

Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs

Completed
NCT06449937Not Applicable

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Recruiting
NCT06328972Not Applicable

Intermittent Multifunctional Nutrition Tube in Cerebral Palsy and Dysphagia

Not Yet Recruiting
NCT06326619

Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients

Completed
NCT06303934Not Applicable

Oral Enteral Nutrition in Infants With Cerebral Palsy and Dysphagia

Completed
NCT06269835Not Applicable

Intermittent Multifunctional Nutrition Tube in Cerebral Palsy and Dysphagia

Recruiting
NCT06185504Not Applicable

Comparison of Intermittent Oro-Esophageal Tube Feeding in Infants With Cerebral Palsy and Dysphagia

Terminated

Drug Details

Intervention Type
PROCEDURE
Total Trials
27